"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene, but contains no active ingredients.

Key facts

Study ID: NCT01694433
Run by: University of California, Los Angeles
People needed: 66
Starts: 2013-02-01
Expected to finish: 2014-01-09
Last updated by the study team: 2019-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Age 18 years or older, of either gender and any racial/ethnic group
Subjects must have clinically evident mild to moderate acne vulgaris of the facial area, IGA scale, grade 2-4
Subjects must understand and sign the informed consent prior to participation
Subjects must be in generally good health
Subjects must be able and willing to comply with the requirements of the protocol

You may not qualify if…

Oral retinoid use within twelve months of entry into the study
Systemic acne therapies (oral antibiotics) within 30 days of entry into the study
Topical acne therapies (retinoids, antibiotics) within 14 days of entry into the study
Non-compliant patients
Pregnant or nursing women
Subjects with a significant medical history or concurrent condition that the investigator(s) feel is not safe for study participation
Subjects with hypercalcemia (hyperparathyroidism, kidney disease)
Subjects who cannot avoid excessive exposure to either natural or artificial sunlight.

Where it is running

UCLA Dermatology — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.